VIRACTA THERAPEUTICS INC. - COMMON STOCK
0.8300
15-5月-24 14:17:22
15 分の遅延
株式
+0.0260
+3.23%
本日の幅
0.7900 - 0.8300
ISIN
N/A
ソース
NASDAQ
-
Viracta Therapeutics Appoints Michael Faerm as Chief Financial Officer
14 5 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Viracta Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
09 5 2024 16:05:01 提供 Nasdaq GlobeNewswire
-
Viracta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
07 5 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
01 4 2024 08:30:00 提供 Nasdaq GlobeNewswire
-
07 3 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
29 2 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Viracta Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
06 2 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Viracta Therapeutics Provides Clinical Update and Outlook for 2024
04 1 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
12 12 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Viracta Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
09 11 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
Viracta Therapeutics to Present at Upcoming Investor Conferences
07 11 2023 16:15:00 提供 Nasdaq GlobeNewswire
-
04 10 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Viracta Therapeutics to Host R&D Day on October 4, 2023
05 9 2023 09:00:00 提供 Nasdaq GlobeNewswire
-
Viracta Therapeutics Announces New Employment Inducement Grant
18 8 2023 16:05:03 提供 Nasdaq GlobeNewswire
-
Viracta Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
14 8 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Viracta Therapeutics Appoints Darrel P. Cohen, M.D., Ph.D. as Chief Medical Officer
07 8 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
28 6 2023 08:00:01 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >